BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20042013)

  • 1. Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation.
    Vieira TC; Bergamin CS; Gurgel LC; Moisés RS
    Pediatr Diabetes; 2010 Nov; 11(7):505-8. PubMed ID: 20042013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Congenital hyperinsulinism in newborn and infant].
    Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P
    Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.
    Pinney SE; MacMullen C; Becker S; Lin YW; Hanna C; Thornton P; Ganguly A; Shyng SL; Stanley CA
    J Clin Invest; 2008 Aug; 118(8):2877-86. PubMed ID: 18596924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism.
    Park SE; Flanagan SE; Hussain K; Ellard S; Shin CH; Yang SW
    Eur J Endocrinol; 2011 Jun; 164(6):919-26. PubMed ID: 21422196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures.
    Darendeliler F; Fournet JC; Baş F; Junien C; Gross MS; Bundak R; Saka N; Günöz H
    J Pediatr Endocrinol Metab; 2002; 15(7):993-1000. PubMed ID: 12199344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell.
    Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A
    J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism.
    Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P
    J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations.
    Kapoor RR; Flanagan SE; James CT; McKiernan J; Thomas AM; Harmer SC; Shield JP; Tinker A; Ellard S; Hussain K
    Diabetologia; 2011 Oct; 54(10):2575-83. PubMed ID: 21674179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation associated with congenital hyperinsulinism.
    Natarajan G; Aggarwal S; Merritt TA
    Am J Perinatol; 2007 Aug; 24(7):401-4. PubMed ID: 17597441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital hyperinsulinism due to a compound heterozygous ABCC8 mutation with spontaneous resolution at eight weeks.
    Kumaran A; Kapoor RR; Flanagan SE; Ellard S; Hussain K
    Horm Res Paediatr; 2010; 73(4):287-92. PubMed ID: 20215776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy.
    Sandal T; Laborie LB; Brusgaard K; Eide SA; Christesen HB; Søvik O; Njølstad PR; Molven A
    Clin Genet; 2009 May; 75(5):440-8. PubMed ID: 19475716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan SE; Kapoor RR; Banerjee I; Hall C; Smith VV; Hussain K; Ellard S
    Clin Genet; 2011 Jun; 79(6):582-7. PubMed ID: 20573158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital hyperinsulinism caused by mutations in ABCC8 (SUR1) gene.
    Thakur S; Flanagan SE; Ellard S; Verma IC
    Indian Pediatr; 2011 Sep; 48(9):733-4. PubMed ID: 21992908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1.
    Macmullen CM; Zhou Q; Snider KE; Tewson PH; Becker SA; Aziz AR; Ganguly A; Shyng SL; Stanley CA
    Diabetes; 2011 Jun; 60(6):1797-804. PubMed ID: 21536946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel de novo mutation in sulfonylurea receptor 1 presenting as hyperinsulinism in infancy followed by overt diabetes in early adolescence.
    Abdulhadi-Atwan M; Bushman J; Tornovsky-Babaey S; Perry A; Abu-Libdeh A; Glaser B; Shyng SL; Zangen DH
    Diabetes; 2008 Jul; 57(7):1935-40. PubMed ID: 18390792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KATP channel mutations in congenital hyperinsulinism.
    Saint-Martin C; Arnoux JB; de Lonlay P; Bellanné-Chantelot C
    Semin Pediatr Surg; 2011 Feb; 20(1):18-22. PubMed ID: 21185999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital Hyperinsulinism Caused by Mutations in
    Butnariu LI; Bizim DA; Păduraru G; Păduraru L; Moisă ȘM; Popa S; Gimiga N; Ghiga G; Bădescu MC; Lupu A; Vasiliu I; Trandafir LM
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial ABCC8 gene deletion mutations causing diazoxide-unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan S; Damhuis A; Banerjee I; Rokicki D; Jefferies C; Kapoor R; Hussain K; Ellard S
    Pediatr Diabetes; 2012 May; 13(3):285-9. PubMed ID: 21978130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose intolerance and diabetes are observed in the long-term follow-up of nonpancreatectomized patients with persistent hyperinsulinemic hypoglycemia of infancy due to mutations in the ABCC8 gene.
    Gussinyer M; Clemente M; Cebrián R; Yeste D; Albisu M; Carrascosa A
    Diabetes Care; 2008 Jun; 31(6):1257-9. PubMed ID: 18339976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.
    Huopio H; Reimann F; Ashfield R; Komulainen J; Lenko HL; Rahier J; Vauhkonen I; Kere J; Laakso M; Ashcroft F; Otonkoski T
    J Clin Invest; 2000 Oct; 106(7):897-906. PubMed ID: 11018078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.